Clinical Trials Browser

Phase 1 × Lapatinib × Head & Neck × Clear all

NCT01947023 2025-11-05

Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery

Phase 1 Active not recruiting

Thyroid Neoplasms

NCT01184482 2013-10-31

TYKERB-ITUX 1

Phase 1 Completed

GastrointestinalHead & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms, Colorectal Neoplasms